![Karin Ann Thacker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Karin Ann Thacker formerly worked at Puma Biotechnology, Inc., as Senior Director & Head-Regulatory Development from 2015 to 2016, Harpoon Therapeutics, Inc., as VP-Regulatory Affairs & Quality Assurance from 2020 to 2022, Gritstone bio, Inc., as Vice President-Global Regulatory Affairs from 2019 to 2020, and Senti Biosciences, Inc., as Vice President-Quality & Regulatory Affairs.
Ms. Thacker received her undergraduate degree and graduate degree from the University of Manitoba.
Tidigare kända positioner av Karin Ann Thacker
| Företag | Position | Slut |
|---|---|---|
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Generell Rådgivare | 2024-05-01 |
| HARPOON THERAPEUTICS, INC. | Generell Rådgivare | 2022-08-01 |
| GRITSTONE BIO, INC. | Generell Rådgivare | 2020-08-01 |
| PUMA BIOTECHNOLOGY, INC. | Företagsledare/Principal | 2016-05-01 |
Karin Ann Thackers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
8
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
